eli lilly hims - Search News

News

Lilly soars

Eli Lilly stock spikes as efficacy of new weight-loss pill rivals Ozempic

The company's breakthrough puts the market one step closer to having an injection-free alternative for the treatment of obesity and diabetes.

Seeking Alpha on MSN · 17d

Eli Lilly weight loss therapy added to Hims & Hers platform (update)

Shares of Hims & Hers Health (NYSE:HIMS) traded higher on Tuesday after the telehealth company announced the addition of branded versions of Eli Lilly’s (NYSE:LLY) popular weight loss therapy tirzepatide for sale on its platform.

The Detroit News · 1d

Lilly soars after weight-loss pill results rival Ozempic’s

Eli Lilly and Co. shares surged after data showed its experimental weight-loss pill worked as well as the Ozempic shot.

Modern Healthcare16d

Eli Lilly denies affiliation with Hims & Hers

Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical company’s weight-loss drug.

1don MSN

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...

HIMS Stock: Time For A Turnaround?

HIMS has experienced similar dramatic drops before. During the 2022 inflation surge, the stock fell 87%, and in 2020, it ...

Modern Healthcare7d

Inside Eli Lilly’s digital health strategy for GLP-1s

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results